| Dec 10, 2025 | D3 Bio | $108.0M Series B | — | IDG Capital, Matrix Partners China, Medicxi, Sequoia Capital, Temasek |
| Apr 8, 2024 | D3 Bio | $62.0M Series A | Francesco De Rubertis | Matrix Partners China |
| Oct 1, 2021 | Structure Therapeutics | $100.0M Series B | Mark Nathan Lampert | Qiming Venture Partners, Casdin Capital, Cormorant Asset Management, Eight Roads Ventures, F-Prime Capital, Hongshan Capital Group (Sequoia Capital China), Janus Henderson Investors, Lilly Asia Ventures, Monashee Investment Management, Sage Partners, Schr"dinger, Stork Capital, Surveyor Capital, Chen Yu, Terra Magnum Capital Partners, TF Capital, Woodline Partners |
| May 28, 2021 | MegaRobo | $65.0M Other Equity | WuXi AppTec | — |
| May 1, 2021 | Engine Biosciences | $43.0M Series A | Amy Schulman | HealthQuest Capital, Koch Fund, Lightspeed Venture Partners, Polaris Partners, Leon Chen, Baidu Ventures, Danhua Capital, EDBI, Goodman Capital, Invus, Nest.Bio Ventures, Vectr Ventures, WI Harper Group |
| Feb 9, 2021 | Drug Farm | $56.0M Other Equity | — | BVCF Management, ZUIG |
| Nov 17, 2020 | D3 Bio | $200.0M Series A | — | Yanling Cao, Hongshan Capital Group (Sequoia Capital China), Matrix Partners China, Temasek |
| Sep 20, 2020 | XWPharma 凯瑞康宁 | $40.0M Series C | — | Hongdao Capital, Huachuang Yida, Johnson & Johnson Innovation, KTB Network, Sany Innovation Investment, Zhongjinghe Group |
| Jun 24, 2020 | Simcha Therapeutics | $25.0M Series A | — | Connecticut Innovations, Hongshan Capital Group (Sequoia Capital China) |
| May 1, 2020 | Insitro | $140.0M Series B | Vijay Pande, PhD | ARCH Venture Partners, Cyberstarts VC, Foresite Capital, GV, Mubadala, Pontifax Venture Capital, quadraScope Venture Fund, Sanofi Ventures, Section 32, Trucks Venture Capital, VZVC, Anne Wojcicki, Alexandria Venture Investments, BlackRock, Casdin Capital, HOF Capital, Third Rock Ventures, Jay Markowitz, Two Sigma Ventures |
| Mar 18, 2020 | Immunocore | $130.0M Series B | Rob Perez | Bill & Melinda Gates Foundation, CCB International, Eli Lilly and Company, JDRF T1D Fund, Rock Springs Capital, RTW Investments, Terra Magnum Capital Partners |
| Feb 18, 2020 | CANbridge Pharmaceuticals | $98.0M Series D | Lefei Sun, WuXi AppTec | Hudson Bay Capital, Derek DiRocco, Tigermed, YuanMing Prudence Fund |
| Apr 1, 2019 | Arrakis Therapeutics | $75.0M Series B | Jakob Loven | 5AM Ventures, Access Biotechnology, Canaan Partners, Connecticut Innovations, Endeavor Venture Funds, HealthQuest Capital, Nextech Invest, OrbiMed, RA Capital, venBio, Advent Life Sciences, Alexandria Venture Investments, Canaan Partners, Celgene, Estate of Henri Termeer, Google Ventures, HBM Healthcare Investments, Omega Funds, Osage University Partners |
| Jan 1, 2019 | Antengene Corporation | $120.0M Series B | Boyu Capital, FountainVest Partners | Qiming Venture Partners, Celgene, Taikang, TF Capital |
| Oct 9, 2018 | Rgenix | $40.0M Series C | Zhongjie Pu | Alexandria Venture Investments, Novo Holdings, Oceanpine Capital, Partnership Fund for New York City, Sofinnova Partners |
| Aug 13, 2018 | Magnolia NeuroSciences | $31.0M Series A | — | 180 Degree Capital, AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund for New York City, Watson Fund |
| Jul 1, 2018 | Verge Genomics | $32.0M Series A | Emily Melton | AME Cloud Ventures, Andreessen Horowitz, Atomico, Basis Set Ventures, BITKRAFT Ventures, Brkfst Club, DCM, Kevin Ding, FJ Labs, Fusion Fund, Goodwater Capital, Great Oaks Venture Capital, Joe Kraus, Hardware Club, Infinite Niches, Jigsaw VC, KRM Interests LLC, Nokia Growth Partners, Hans Tung, Pegasus Tech Ventures, Primitive Ventures, Sarah Smith Fund, Tiger Global Management, UpHonest Capital, Ding Zhou, Ed Baker, Gabriel Jarrosson, Josh Mohrer, Nimit Maru, Rashaun Williams, Agent Capital, ALS Investment Fund, OS Fund, Edward Hu |
| May 16, 2018 | FogPharma | $66.0M Series B | Leon Chen | Blue Pool Capital, Boyu Capital, Deerfield Management, Krishna Yeshwant, Horizons Ventures, Leerink Partners, Nan Fung Group |
| Apr 23, 2018 | NuProbe | $11.0M Series A | Neil Shen, Victor Chenyang Shi | — |
| Mar 8, 2018 | JW Therapeutics | $90.0M Series A | Hongshan Capital Group (Sequoia Capital China), Temasek, YuanMing Capital | AVICT Global, Juno Therapeutics, Yipu Capital |
| Mar 1, 2018 | Hua Medicine | $120.0M Series D | — | ARCH Venture Partners, Flagship Ventures, F-Prime Capital Partners, Meritech Capital Partners, Venrock, 6 Dimensions Capital, Ally Bridge Group, AVICT Global, Blue Pool Capital, Eight Roads Ventures, F-Prime Capital, GIC, Harvest Investments, Adrian Cheng, Mirae Asset, Ping An Ventures |
| Jan 31, 2018 | Engine Biosciences | $10.0M Seed | Leon Chen, Shoucheng Zhang | Baidu Ventures, EDBI, Nest.Bio Ventures, Pavilion Capital, WI Harper Group |
| Aug 1, 2017 | UNITY Biotechnology | $35.0M Series B | ARCH Venture Partners, Venrock, Fidelity Management & Research Company, Partner Fund Management | Foundry Group, High Alpha, LOI Venture, Menlo Ventures, Vivo Capital, Rudy Gadre, Bezos Expeditions, Cycad Group, Founders Fund, Invus Opportunities, Mayo Clinic, Pivotal Alpha Limited, Three Lakes Partners, Vulcan Capital |
| Jul 25, 2017 | Rodeo Therapeutics | $5.9M Series A | — | AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Johnson & Johnson Innovation, Watson Fund, WRF Capital |
| May 1, 2017 | CANbridge Pharmaceuticals | $25.0M Series B | Lapam Capital | Qiming Venture Partners, Biossom Investment Management, Haoyue Capital, Yanyuan Capital, YuanMing Capital |
